LEADER 00912nam0-2200313---450-
001 990009199910403321
005 20100729114741.0
010   $a978-1-4200-6424-7
035   $a000919991
035   $aFED01000919991
035   $a(Aleph)000919991FED01
035   $a000919991
100   $a20100617d2009----km-y0itay50------ba
101 0 $aeng
102   $aUS
105   $a--------001yy
200 1 $aintroduction to spatial econometrics$fJames LeSage, r. Kelley Pace
210   $aBoca Raton$cchapman&Hall/CRC$d[2009]
215   $aXIII, 354 p.; [2] p. di tav.$cill.$d25 cm
225 1 $aStatistics
700  1$aLesage,$bJames P.$0285125
701  1$aPace,$bR. Kelley$0285126
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990009199910403321
952   $a62 330.115 LES$b10443$fDAGEA
959   $aDAGEA
996   $aIntroduction to spatial econometrics$9775001
997   $aUNINA

LEADER 02696nam  2200589Ia 450 
001 9910465665703321
005 20200520144314.0
010   $a1-282-91713-7
010   $a9786612917134
010   $a0-309-15955-5
035   $a(CKB)2560000000069605
035   $a(EBL)3378699
035   $a(SSID)ssj0000434285
035   $a(PQKBManifestationID)11275916
035   $a(PQKBTitleCode)TC0000434285
035   $a(PQKBWorkID)10402025
035   $a(PQKB)11209227
035   $a(MiAaPQ)EBC3378699
035   $a(Au-PeEL)EBL3378699
035   $a(CaPaEBR)ebr10433654
035   $a(CaONFJC)MIL291713
035   $a(OCoLC)703277537
035   $a(EXLCZ)992560000000069605
100   $a20101028d2010      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aChallenges and opportunities in using residual newborn screening samples for translational research$b[electronic resource] $eworkshop summary /$fSteve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$d2010
215   $a1 online resource (85 p.)
300   $aDescription based upon print version of record.
311   $a0-309-15954-7 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""Abbreviations and Acronyms""; ""1 Introduction""; ""2 Newborn Screening as a Public Health Program""; ""3 Uses of Residual Newborn Screening Samples in Research""; ""4 Concerns About the Use of Residual Newborn Screening Samples""; ""5 Review and Consent in the Use of Residual Newborn Screening Samples""; ""6 Parental and Public Education""; ""7 Workshop Overview and Wrap-Up""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker Biographical Sketches""
606   $aGenetic disorders$xDiagnosis
606   $aNewborn infants$xDiseases$xDiagnosis
608   $aElectronic books.
615  0$aGenetic disorders$xDiagnosis.
615  0$aNewborn infants$xDiseases$xDiagnosis.
676   $a618.9
701   $aOlson$b Steve$f1956-$0488724
701   $aBerger$b Adam C$0977979
712 02$aInstitute of Medicine (U.S.).$bRoundtable on Translating Genomic-Based Research for Health.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910465665703321
996   $aChallenges and opportunities in using residual newborn screening samples for translational research$92255510
997   $aUNINA